Technical Data
D9016-10
Dopamine Receptor, D2L, D2S
Description:
The Dopamine D2 Receptor is one of the five types (D1 to D5) of receptors for dopamine. The activity of this receptor is mediated by G proteins which inhibit adenylyl cyclase. Two isoforms are reported for the D2 Dopamine Receptor, isoform 1 and isoform 2 which are expressed in the pituitary and brain; Isoform 1 is expressed seven times more than isoform 2 in the caudate nucleus.

Applications:
Suitable for use in ELISA, Western Blot, Immunoprecipitation and Immunohistochemistry. Other applications have not been tested.

Recommended Dilutions:
ELISA: 0.5-1.0ug/ml
Western Blot: 1:1000. Detected Dopamine Receptor D2 on 10ug of human brain lysates.
Immunoprecipitation: 1-10ug/ml. Use 100-400ug of protein. An antibody made to this epitope has been shown to immunoprecipitate both the long and short forms.
Immunohistochemistry (Paraformaldehyde fixed sections): 2-10ug/ml
Optimal dilutions to be determined by the researcher.

Positive Control:
Monkey brain tissue, rat or mouse brain lysate

Recommended Secondary Antibodies:
I1904-39: IgG, X-Adsorbed (HRP) Pab Gt x Rb
I1904-40A: IgG, H&L, X-Adsorbed (HRP) Pab Gt x Rb
I1904-46Q: IgG, H&L (HRP) Pab Gt x Rb

Storage and Stability:
May be stored at 4░C for short-term only. Aliquot to avoid repeated freezing and thawing. Store at -20░C. Aliquots are stable for 12 months after receipt. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap.
TypeIsotypeCloneGrade
PabIgGAffinity Purified
SizeStorageShippingSourceHost
50ug-20░CBlue IceHumanRabbit
Concentration:
~1mg/ml
Immunogen:
Synthetic peptide corresponding to the cytoplasmic loop #3 (28aa) of the human D2 receptor (NM_000795.2).
Purity:
Purified by immunoaffinity chromotography.
Form
Supplied as a liquid in PBS, pH 7.4, 0.1% BSA.
Specificity:
Recognizes human Dopamine Receptor D2 short and long form at ~50kD. No significant homology with other dopamine receptors (D1 and D3-D5). Species Crosseactivity: monkey, mouse and rat.
Intended for research use only. Not for use in human, therapeutic, or diagnostic applications.
1. EMBO 8: 4025 (1989). 2.áPNAS (1989) 86: 9762. 3.áNature 342: 926 (1990). 4.áNature 342: 923 (1989). 5.áMol. Pharmacol. 43: 666-676 (1993). 6.áBrain Res. 575: 309-314 (1992). 7.áJ. Neurochem. 57: 1363-1369 (1991). 8.áBBRC 184: 661-667 (1992). 9.áBrain Res. 578: 244-250 (1992). 10.áLife. Sci. 51: 1509-1516 (1992). 11. Gutierrez-Mecinas, M., et al., Eur. J. Neurol. 22: 1357-1367 (2005). 12. Lee, S.P., et al., J. Biol. Chem. 279: 35,671-35,678 (2004). 13. Lei, W., et al., J. Neurosci. 24: 8289-8299 (2004). 14. Macey, T.A., et al., Mol. Pharmacol. 66: 1635-1642 (2004). 15. Mengual, E., et al., Synapse 43: 151-162 (2002). 16. Wang, H., et al., J. Comparative Neurology 442: 392-404 (2002). 17. Neve, K.A., et al., Mol. Pharmacol. 60: 373-381 (2001).